BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 1999
View Archived Issues
Transkaryotic Therapies: Q4 and FY98 highlights
Read More
Eclipse to hold special shareholder meeting to consider merger with CardioGenesis
Read More
AxyS initiates phase Ib studies of APC-2059 in psoriasis
Read More
AxyS initiates phase Ib studies of APC-2059 in acute IBD
Read More
Health Canada approves first active wound-healing agent
Read More
NPS Pharmaceuticals: Q4 and year-end 1998 highlights
Read More
Agouron presents Women First study results at ROI conference
Read More
New agents for prion diseases available for licensing from NIH
Read More
Pharmacia & Upjohn: Q4 1998 highlights
Read More
Ilex Oncology: Q4 and year-end 1998 highlights
Read More
Nippon Shinyaku: Annual Report 1998
Read More
Imidazole cytokine-suppressive antiinflammatory compounds from SB
Read More
Astra discloses novel neuronal N-type calcium channel ligands
Read More
New ribose-based antibacterial agents in development at HMR
Read More
IL-1beta inhibitors from ADIR useful for inflammatory conditions
Read More
Novel, orally bioavailable anticoagulants discovered at Lilly
Read More
ZD-4522 enters accelerated phase III trial program
Read More
First pivotal trial results reported for marimastat; BB to assess implications for development
Read More
Fibrinogen antagonist does not prevent restenosis after stent implantation in dog model
Read More
Phase III trial data support leflunomide as useful RA treatment option
Read More
Corixa completes acquisition of Anergen
Read More
Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure
Read More
Clinical study elucidates mechanism of action of antiplatelet compound E-5510
Read More
Icos collaborates with Array BioPharma on new drug development
Read More
Company Profile: NewBiotics
Read More
Ontak available this month in U.S.
Read More
